[vslist] ARVO 2004 SIG

[Marilyn Schneck]

ARVO 2004 SIG meeting, Wednesday April 28, 1:30-3:00 p.m. Room 114

Epidemiology of Visual Impairment: What's holding up the research?

Organizer: Gislin Dagnelie, PhD, JHU Lions Vision Center, Wilmer Eye 
Institute, 550 N. Broadway, 6th fl., Baltimore, MD, 21205-2020. 
Phone: 410-614-4822, Fax: 410-955-1829, E-mail: gdagnelie at jhmi.edu

Visual impairment research straddles many of the traditional 
boundaries in ARVO.  In addition to its traditional ties to 
psychophysical and visual performance testing, the study of visual 
impairment in the population should also have strong ties to 
epidemiology and clinical research, to the study of (abnormal) visual 
development, and to the study of visual outcomes in many areas of 
ophthalmology.  In this session, we want to combine the experiences 
of researchers who have studied visual impairment and visual outcomes 
in population-based studies with the expertise of specialists in the 
organization of clinical trials, and those developing visual and 
functional outcome measures, to address questions such as:  How can 
we improve the detection and treatment of visual impairment in the 
population?  What is required to validate (and increase) the efficacy 
of vision rehabilitation programs? How can clinical trialists 
contribute in studying the impact of visual impairment?  What are 
relevant functional outcome measures?  Moderators: Gislin Dagnelie 
and Robert Massof. Speakers:  Marilyn Schneck, PhD, University of 
California Berkeley; Maureen Maguire, PhD, University of 
Pennsylvania; Susana Chung, PhD, University of Houston; Stanley Azen, 
PhD, University of Southern California; Gerald McGwin, PhD, 
University of Alabama Birmingham; Gary Rubin, PhD, University College 
London; Robert Massof, PhD, Johns Hopkins University.

-- 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://visionscience.com/pipermail/visionlist/attachments/20040413/45c1d5f3/attachment.html